In the oral presentation, the investigators reported ongoing improved survival compared to historical controls, with 3 out of ...

Study reveals potential of AI-powered tumor microenvironment assessment in predicting treatment outcomes in rare cancer patients receiving ...

Advertisement Specific types of immune cells unleashed by cancer immunotherapy appear to cause myocarditis ... Nov. 7 (UPI) - ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

AMPLIFY-7P Phase 2 randomized study anticipated to complete enrollment in Q4 2024; formal interim analysis of disease-free survival ("DFS") expected in H1 2025Poster presentation at the Society for Im ...

Lincoln Melling, from Shevington, died on Monday, only a few days after his 11th birthday. He is survived by his parents Dan ...

AMPLIFY-7P Phase 2 randomized study anticipated to complete enrollment in Q4 2024; formal interim analysis of disease-free survival (“DFS”) expected in H1 2025 Poster presentation at the Society for ...

Notes payable, plus accrued interest, totaled approximately $6.9 million. The current portion of the notes payable plus ...